Quidel Corporation Partners With the Bay Area Lyme Foundation to Heighten Public Awareness of Lyme Disease
April 13 2021 - 8:00AM
Business Wire
With Lyme disease season breaking out across the United States,
Quidel Corporation announced today that it has partnered with the
Bay Area Lyme (BAL) Foundation to help heighten public awareness to
this alarming health condition that afflicts as many as 400,000
Americans each year. Quidel is the nation’s leading developer of
rapid Lyme disease testing.
As part of its collaboration, Quidel will serve as the sponsor
for BAL’s series of free speaker forums that focus on research and
science in the field of Lyme disease as well as Lyme disease
prevention. These events provide new information on various Lyme
topics in an open-discussion format, all designed to bring
awareness around the Lyme disease epidemic with rapid ways to
diagnose and treat it. Each of these events will feature a
scientific researcher paired with a Lyme survivor sharing their
inspirational story.
The first in the series will be held via zoom on May 19 and will
discuss the topic of “Herbal Treatments for Tick-Borne Diseases.”
Speakers will include Sunjya Schweig, M.D., who has been studying,
teaching and practicing integrative and functional medicine for
over 25 years and is a member of the BAL's scientific advisory
board. Also participating will be Lia Gaertner, a BAL board member
and the organization’s director of education and outreach. More
information is available at
speakerseries@bayarealyme.org.
Quidel will also be a primary sponsor of BAL’s Emerging Leader
Awards, which recognize both established and up-and-coming
researchers who bring creative thinking to the field of Lyme
disease. These grants support new and innovative projects and aim
to attract aspiring new scientific talent to the field of Lyme. In
addition, Quidel will sponsor the annual LymeAid Gala, the
foundation’s annual benefit dinner and live concert to be held
later this year.
“The fact that symptoms of Lyme disease may not appear for weeks
makes it all the more important that people take steps to avoid
getting a tick bite, be aware of Lyme’s early warning signs, and
then get tested immediately if they think they may have contracted
it,” said Cheryl Miller, vice president of market development at
Quidel. “That’s why we are so honored to be partnering with the Bay
Area Lyme Foundation. Together, we work to heighten public
awareness of the disease and advance scientific research in testing
and treatment for Lyme.”
Lyme disease is a bacterial infection that occurs when people
are bitten by an infected deer tick. It can strike anyone at any
age and can lead to a number of serious, life-threatening problems
if not caught early. Leading the way in Lyme disease testing is
Quidel’s innovative Sofia® 2 Lyme FIA. This test provides the
patient as well as his or her physician with indicative results
within 15 minutes, as opposed to days, which has historically been
the norm. Performed in the privacy of a doctor’s office or local
clinic, it is also the only test that can get results from a simple
finger prick of blood.
About Quidel Corporation
Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of
diagnostic solutions at the point of care, delivering a continuum
of rapid testing technologies that further improve the quality of
health care throughout the globe. An innovator for over 40 years in
the medical device industry, Quidel pioneered the first FDA-cleared
point-of-care test for influenza in 1999 and was the first to
market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted
brand names, Sofia®, Solana®, Lyra®, Triage® and QuickVue®,
Quidel’s comprehensive product portfolio includes tests for a wide
range of infectious diseases, cardiac and autoimmune biomarkers, as
well as a host of products to detect COVID-19. With products made
in America, Quidel’s mission is to provide patients with immediate
and frequent access to highly accurate, affordable testing for the
good of our families, our communities and the world. For more
information about Quidel, visit quidel.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210413005531/en/
Jim Yeager 818.264.6812 jim@breakwhitelight.com
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Jul 2023 to Jul 2024